专利检索 ap:("BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM" OR "MEDCARA PHARMACEUTICALS, LLC") AND inv:"Robert A. JOSEPHS" 第 1 页

1.

发明申请
FORMULATIONS OF TESTOSTERONE AND METHODS OF TREATMENT THEREWITH 审中-公开

公开(公告)号：US20190298736A1

公开(公告)日：2019-10-03

申请号：US16382607

申请日：2019-04-12

申请人： BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM , MEDCARA PHARMACEUTICALS, LLC

发明人： Robert A. JOSEPHS , Craig HERMAN

IPC分类号： A61K31/5685 , A61K31/573 , A61K31/568 , A61K45/06 , A61K9/107 , A61K47/14 , A61K9/00 , A61K47/44

摘要： The present disclosure relates to novel pharmaceutical composition for the administration of testosterone or testosterone derivatives. The present disclosure also provides methods of treatment of diseases and disorders associated with fear and anxiety, a decrease in libido, or hypogonadism.

2.

发明申请
FORMULATIONS OF TESTOSTERONE AND METHODS OF TREATMENT THEREWITH 审中-公开

公开(公告)号：US20170281644A1

公开(公告)日：2017-10-05

申请号：US15507246

申请日：2015-08-28

申请人： BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM , MEDCARA PHARMACEUTICALS, LLC

发明人： Robert A. JOSEPHS , Craig HERMAN

IPC分类号： A61K31/5685 , A61K45/06 , A61K9/107 , A61K47/44 , A61K47/14

CPC分类号： A61K31/5685 , A61K9/0043 , A61K9/107 , A61K31/568 , A61K31/573 , A61K45/06 , A61K47/14 , A61K47/44 , A61K2300/00

摘要： The present disclosure relates to novel pharmaceutical composition for the administration of testosterone or testosterone derivatives. The present disclosure also provides methods of treatment of diseases and disorders associated with fear and anxiety, a decrease in libido, or hypogonadism.

3.

发明申请
FORMULATIONS OF TESTOSTERONE AND METHODS OF TREATMENT THEREWITH 有权

公开(公告)号：US20220387447A1

公开(公告)日：2022-12-08

申请号：US17814591

申请日：2022-07-25

申请人： BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM , MEDCARA PHARMACEUTICALS, LLC

发明人： Robert A. JOSEPHS , Craig HERMAN

IPC分类号： A61K31/568 , A61K47/14 , A61K47/44 , A61K9/00 , A61K9/107 , A61K9/12 , A61P15/10 , A61P25/22 , A61P15/08 , A61K31/573

摘要： The present disclosure relates to novel pharmaceutical composition for the administration of testosterone or testosterone derivatives using an aqueous nasal administration. The present disclosure also provides methods of treatment of diseases and disorders associated with fear and anxiety, a decrease in libido, or hypogonadism.

4.

发明申请
FORMULATIONS OF TESTOSTERONE AND METHODS OF TREATMENT THEREWITH 有权

公开(公告)号：US20210030767A1

公开(公告)日：2021-02-04

申请号：US16996780

申请日：2020-08-18

申请人： BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM , MEDCARA PHARMACEUTICALS, LLC

发明人： Robert A. JOSEPHS , Craig HERMAN

IPC分类号： A61K31/5685 , A61K45/06 , A61K31/568 , A61K31/573 , A61K9/00 , A61K47/14 , A61K47/44 , A61K9/107

摘要： The present disclosure relates to novel pharmaceutical composition for the administration of testosterone or testosterone derivatives. The present disclosure also provides methods of treatment of diseases and disorders associated with fear and anxiety, a decrease in libido, or hypogonadism.

5.

发明申请
FORMULATIONS OF TESTOSTERONE AND METHODS OF TREATMENT THEREWITH 审中-公开

公开(公告)号：US20190091239A1

公开(公告)日：2019-03-28

申请号：US16081485

申请日：2017-03-02

申请人： Board of Regents, the University of Texas System , MedCara Pharmaceuticals, LLC

发明人： Robert A. JOSEPHS , Craig HERMAN

IPC分类号： A61K31/568 , A61K47/14 , A61K47/44 , A61K9/00 , A61K31/573 , A61P25/22 , A61P15/10 , A61P15/08 , A61K9/107

摘要： The present disclosure relates to novel pharmaceutical composition for the administration of testosterone or testosterone derivatives using an aqueous nasal administration. The present disclosure also provides methods of treatment of diseases and disorders associated with fear and anxiety, a decrease in libido, or hypogonadism.